Risk of cancer with cyclosporine in psoriasis.
Arellano
F
F
Zeneca Pharmaceuticals, Wilmington, DE 19806, USA.
D000328:Adult; D000367:Age Factors; D002986:Clinical Trials as Topic; D016572:Cyclosporine / Q000009:adverse effects* / Q000627:therapeutic use*; D003625:Data Collection; D005431:Florida / Q000453:epidemiology; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects* / Q000627:therapeutic use*; D015994:Incidence; D008824:Michigan / Q000453:epidemiology; D008875:Middle Aged; D009369:Neoplasms / Q000139:chemically induced* / Q000453:epidemiology*; D011565:Psoriasis / Q000188:drug therapy*; D018570:Risk Assessment; D012307:Risk Factors; D013997:Time Factors
D007166:Immunosuppressive Agents; D016572:Cyclosporine